Feb 19, 2026 08:24AM Piper Sandler on Livanova (LIVN): 'Favorite SMID Value Name On Our List'

Jan 26, 2026 08:19AM KeyBanc on Medical Technology: 'From Reset to Rebound?'

Jan 7, 2026 07:58AM Livanova (LIVN) PT Raised to $70 at Stifel: A More-Consistent Growth Engine

Dec 19, 2025 02:20AM KeyBanc Starts Livanova (LIVN) at Overweight

Dec 2, 2025 09:03AM LivaNova names Lucile Blaise global head of sleep apnea unit

Nov 24, 2025 09:00AM LivaNova gets higher Medicare reimbursement for epilepsy device procedures

Nov 12, 2025 03:28PM LivaNova (LIVN) Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day

Nov 7, 2025 04:08AM Needham Reiterates Buy Rating on Livanova (LIVN)

Nov 5, 2025 12:07PM Livanova (LIVN) PT Raised to $65 at Stifel

Nov 5, 2025 06:04AM LivaNova plc (LIVN) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance

Oct 1, 2025 04:19AM Goldman Sachs Downgrades Livanova (LIVN) to Neutral

Aug 21, 2025 05:29AM Livanova (LIVN) PT Raised to $58 at Barclays

Aug 18, 2025 09:00AM LivaNova launches Essenz perfusion system in China's cardiac surgery market

Aug 8, 2025 05:12AM Livanova (LIVN) PT Raised to $168 at Goldman Sachs

Aug 7, 2025 07:14AM Livanova (LIVN) PT Raised to $65 at Mizuho

Aug 6, 2025 06:03AM LivaNova plc (LIVN) Tops Q2 EPS by 18c ; Offers Guidance

Jun 13, 2025 08:26AM Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names

Jun 5, 2025 08:16AM LivaNova plc (LIVN) completes CORE-VNS study

Jun 5, 2025 08:01AM LivaNova (LIVN) Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy

Jun 4, 2025 08:01AM LivaNova (LIVN) Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

May 20, 2025 04:19AM Wolfe Research Upgrades Livanova (LIVN) to Outperform

May 7, 2025 04:01PM Livanova (LIVN) PT Raised to $79 at Jefferies

May 7, 2025 06:07AM LivaNova plc (LIVN) Tops Q1 EPS by 12c ; Offers Guidance

Mar 17, 2025 10:18AM Barclays Maintains Livanova (LIVN) at Equalweight

Mar 17, 2025 09:57AM Livanova (LIVN) PT Lowered to $74 at Jefferies

Mar 17, 2025 08:16AM Needham Reiterates Buy Rating on Livanova (LIVN)

Mar 10, 2025 04:38AM Goldman Sachs Reiterates Buy Rating on Livanova (LIVN)

Feb 26, 2025 05:53AM Livanova (LIVN) PT Lowered to $60 at Mizuho

Feb 26, 2025 01:06AM Wolfe Research Downgrades Livanova (LIVN) to Peerperform

Feb 25, 2025 05:50PM Livanova (LIVN) PT Lowered to $60 at Stifel

Feb 25, 2025 06:06AM LivaNova plc (LIVN) Tops Q4 EPS by 1c ; Offers Guidance

Jan 28, 2025 08:39AM Stifel Reiterates Buy Rating on Livanova (LIVN)

Dec 23, 2024 09:58AM Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval

Nov 25, 2024 07:11AM Needham Reiterates Buy Rating on Livanova (LIVN)

Nov 11, 2024 04:06PM LivaNova plc (LIVN) Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints

Oct 30, 2024 06:01AM LivaNova plc (LIVN) Tops Q3 EPS by 18c

Oct 8, 2024 09:00AM LivaNova plc (LIVN) Appoints Susan Podlogar as Director

Oct 4, 2024 04:14AM Goldman Sachs Starts Livanova (LIVN) at Buy

Sep 17, 2024 02:20PM LivaNova plc (LIVN) January 65 calls active as share price up 4%

Sep 17, 2024 03:12AM Baird Upgrades Livanova (LIVN) to Outperform

Jul 31, 2024 01:23PM Livanova (LIVN) PT Raised to $75 at Needham

Jul 31, 2024 06:02AM LivaNova plc (LIVN) Tops Q2 EPS by 15c, provides guidance

Jul 25, 2024 07:23AM Livanova (LIVN) PT Raised to $72 at Stifel

Jul 16, 2024 06:53AM Livanova (LIVN) PT Lowered to $57 at Baird